Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...
Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...
Q4 2024 Earnings Call Transcript February 18, 2025 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...
YourBio Health, a pioneer in remote blood collection technology, announced today the appointments of Michael Mina, M.D., Ph.D. as Chief Scientific Officer, Chester Robson D.O., as Chief Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback